A smart ring that wants to replace your blood pressure cuff
The Signal Ring is a new hypertension monitoring wearable that claims to deliver direct, cuffless blood pressure readings from your finger using optical sensors and algorithms, aiming to make continuous blood pressure tracking as easy and discreet as wearing a normal ring. This is the core promise behind Vital Signals’ debut device, and it is a big one. The three‑year‑old startup has announced the Signal Ring as a USD 399 (approx. RM1,840) smart ring that reports systolic and diastolic values without an arm cuff or any calibration routine at setup. Pre‑orders are open now with a sizing kit included, and shipments are expected to begin later in October. In other words, this is not a distant concept; it is a product asking people with high blood pressure to trust a ring over their tried‑and‑true cuff.
How cuffless blood pressure monitoring in a ring is supposed to work
Vital Signals is tight‑lipped on the exact method, but the Signal Ring clearly sits in the cuffless blood pressure ring camp that depends on optical sensing and algorithmic modeling rather than physical inflation. The product page says the ring uses advanced optical sensors and specialized algorithms to detect blood pressure fluctuations throughout the day instead of single cuff readings that can be skewed by momentary factors. That points straight to PPG‑based sensing, which experts flag as sensitive to motion, darker skin tones, cold fingers, poor circulation, and irregular heartbeats. According to Lindsey Rosman, these variables can distort the waveform and “ring fit and finger position add further variability.” Vital Signals counters with scale: the company cites a 451‑person clinical study and claims its readings meet international accuracy standards for blood pressure cuffs, with more studies underway. Until those data are public, buyers are being asked to accept a black‑box algorithm on faith.
From sleep tracking to real hypertension management
The smart ring market has been content with heart rate, activity, and sleep trends, but the Signal Ring pushes toward full smart ring blood pressure tracking as its main identity. Vital Signals is betting that continuous, calibration‑free readings and overnight trend graphs will set it apart from rivals that only infer vascular changes rather than report blood pressure numbers. The ring can capture automatic readings, letting users collect nighttime data and review patterns over time, while also supporting guided, sit‑down sessions triggered in the app. If it works as promised, that matters: nearly half of adults have high blood pressure, which raises the risk of stroke and heart disease, and many struggle to monitor it regularly with traditional cuffs. A cuffless, always‑on hypertension monitoring wearable could change daily care from occasional snapshots to a rich timeline of how stress, sleep, and medication shape your cardiovascular reality.
What early buyers should be skeptical about
For all the excitement, it is reckless to treat this first‑generation cuffless blood pressure ring as a drop‑in replacement for a medical‑grade cuff. The device has not received regulatory clearance, and even classic office measurements suffer from issues like white‑coat hypertension; adding motion, fit, skin tone, and circulation challenges on top only raises the stakes. Health experts warn that inaccurate readings can create “unnecessary worry or false assurance,” which is far from a minor side effect when you are dealing with stroke and heart‑disease risk. There is also a practical drawback: data processing happens in the cloud, so your phone needs a connection to display blood pressure results. No subscription is required, but you are still tying a critical health metric to a startup’s servers, algorithms, and long‑term survival. Early adopters should treat every reading as one data point to discuss with a doctor, not a standalone diagnostic.
Will Signal Ring reshape cardiac monitoring—or overpromise?
Vital Signals is aiming straight at the future of cardiac monitoring: a discrete ring that continuously maps your blood pressure patterns, claims international‑standard accuracy, and sells for a one‑time USD 399 (approx. RM1,840) with no subscription fees. If its clinical results back up the marketing, the Signal Ring could help users and clinicians see nighttime dips, stress responses, and treatment effects that single cuff readings miss, and that would be a substantial shift in how hypertension is managed day to day. But until independent data and regulatory review catch up, the most sensible stance is cautious optimism. The Signal Ring shows where smart ring blood pressure technology is heading, not where it safely is today. Use it, if you buy it, as a powerful experiment: a way to learn your patterns, log questions for your doctor, and help pressure the industry to prove that elegant wearables can also be trustworthy medical tools.
